January 31, 2015 8:07 PM ET


Company Overview of Cognosci Inc.

Company Overview

Cognosci Inc. engages in discovering and developing anti-inflammatory compounds for the treatment of neuroinflammatory diseases. Its products include COG112 to treat multiple sclerosis; and COG1410 to treat traumatic brain injuries and Alzheimer’s disease. The company also offers products to treat ischemic stroke/subarachnoid hemorrhage, spinal cord injury, Parkinson's disease, rheumatoid arthritis, and sepsis. Cognosci was founded in 2000 and is based in Research Triangle Park, North Carolina.

79 T. W. Alexander Drive

4401 Research Commons

Research Triangle Park, NC 27709

United States

Founded in 2000





Key Executives for Cognosci Inc.

Vice President of Research & Business Development and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
DPT Laboratories, Ltd. United States
Centella Therapeutics, Inc. United States
CG Nutritionals, Inc. United States
Pharmasol Corporation United States
DrugAbuse Sciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cognosci Inc., please visit www.cognosci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.